Table III.
Multivariate analysis assessing risk of infection with non-cephalosporin alternatives.
Variable | OR (95% CI) | p-value |
---|---|---|
PJI risk without cefazolin | 2.267 (1.2 to 4.4) | 0.015* |
PJI risk without cefazolin: adjusted | 2.389 (1.2 to 4.6) | 0.010† * |
Adjusted for male sex, BMI, and rheumatologic history.
Statistically significant.
Multivariate logistic regression.
CI, confidence interval; OR, odds ratio; PJI, periproshetic joint infection.